Home Versus In-centre Haemodialysis for End-stage Kidney Disease

Overview

Journal Cochrane Database Syst Rev

Publisher Wiley

Specialties General Medicine
Health Services

Date 2014 Nov 21

PMID 25412074

Citations 12

Authors

Suetonia C Palmer

Andrew R Palmer

Jonathan C Craig

David W Johnson

Paul Stroumza

Luc Frantzen

Miguel Leal

Susanne Hoischen

Jorgen Hegbrant

Giovanni F M Strippoli

Affiliations

Soon will be listed here.

Abstract

Background: Home haemodialysis is associated with improved survival and quality of life in uncontrolled studies. However, relative benefits and harms of home versus in-centre haemodialysis in randomised controlled trials (RCTs) are uncertain.

Objectives: To evaluate the benefits and harms of home haemodialysis versus in-centre haemodialysis in adults with end-stage kidney disease (ESKD).

Search Methods: The Cochrane Renal Group's Specialised Register was searched up to 31 October 2014.

Selection Criteria: RCTs of home versus in-centre haemodialysis in adults with ESKD were included.

Data Collection And Analysis: Data were extracted by two investigators independently. Study risk of bias and other patient-centred outcomes were extracted. Insufficient data were available to conduct meta-analyses.

Main Results: We identified a single cross-over RCT (enrolling 9 participants) that compared home haemodialysis (long hours: 6 to 8 hours, 3 times/week) with in-centre haemodialysis (short hours: 3.5 to 4.5 hours, 3 times/weeks) for 8 weeks in prevalent home haemodialysis patients. Outcome data were limited and not available for the end of the first phase of treatment in this cross-over study which was at risk of bias due to differences in dialysate composition between the two treatment comparisons.Overall, home haemodialysis reduced 24 hour ambulatory blood pressure and improved uraemic symptoms, but increased treatment-related burden of disease and interference in social activities. Insufficient data were available for mortality, hospitalisation or dialysis vascular access complications or treatment durability.

Authors' Conclusions: Insufficient randomised data were available to determine the effects of home haemodialysis on survival, hospitalisation, and quality of life compared with in-centre haemodialysis. Given the consistently observed benefits of home haemodialysis on quality of life and survival in uncontrolled studies, and the low prevalence of home haemodialysis globally, randomised studies evaluating home haemodialysis would help inform clinical practice and policy.

Citing Articles

Home versus in-centre haemodialysis for people with kidney failure.

Cheetham M, Ethier I, Krishnasamy R, Cho Y, Palmer S, Johnson D Cochrane Database Syst Rev. 2024; 4:CD009535.

PMID: 38588450 PMC: 11001293. DOI: 10.1002/14651858.CD009535.pub3.

Main Barriers to the Introduction of a Home Haemodialysis Programme in Poland: A Review of the Challenges for Implementation and Criteria for a Successful Programme.

Kendzia D, Lima F, Zawierucha J, Busink E, Apel C, Malyszko J J Clin Med. 2022; 11(14).

PMID: 35887931 PMC: 9321469. DOI: 10.3390/jcm11144166.

Evaluation of the experience with the use of telemedicine in a home dialysis program-a qualitative and quantitative study.

Scofano R, Monteiro A, Motta L BMC Nephrol. 2022; 23(1):190.

PMID: 35590287 PMC: 9117587. DOI: 10.1186/s12882-022-02824-5.

Combination of Multiple Hemodialysis Modes: Better Treatment Options for Patients Under Maintenance Hemodialysis.

Zhang Z, Li M, Yu H, Zhao J, Xiao F, Xuan F Ther Clin Risk Manag. 2021; 17:127-133.

PMID: 33542633 PMC: 7853439. DOI: 10.2147/TCRM.S288023.

Bonenkamp A, van Eck van der Sluijs A, Hoekstra T, Verhaar M, van Ittersum F, Abrahams A Kidney Med. 2020; 2(2):139-154.

PMID: 32734235 PMC: 7380444. DOI: 10.1016/j.xkme.2019.11.005.

References

Culleton B, Walsh M, Klarenbach S, Mortis G, Scott-Douglas N, Quinn R . Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007; 298(11):1291-9. DOI: 10.1001/jama.298.11.1291. View

Walsh M, Manns B, Klarenbach S, Quinn R, Tonelli M, Culleton B . The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot study. BMC Nephrol. 2006; 7:2. PMC: 1458958. DOI: 10.1186/1471-2369-7-2. View

Saran R, Bragg-Gresham J, Levin N, Twardowski Z, Wizemann V, Saito A . Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006; 69(7):1222-8. DOI: 10.1038/sj.ki.5000186. View

Vecchio M, Navaneethan S, Johnson D, Lucisano G, Graziano G, Saglimbene V . Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev. 2010; (12):CD007747. DOI: 10.1002/14651858.CD007747.pub2. View

Unruh M, Sanders M, Redline S, Piraino B, Umans J, Chami H . Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study. Am J Kidney Dis. 2008; 52(2):305-13. PMC: 2582326. DOI: 10.1053/j.ajkd.2008.04.019. View

Walsh M, Manns B, Klarenbach S, Tonelli M, Hemmelgarn B, Culleton B . The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodial Int. 2010; 14(2):174-81. DOI: 10.1111/j.1542-4758.2009.00418.x. View

Chan C, Greene T, Chertow G, Kliger A, Stokes J, Beck G . Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging. 2012; 5(2):251-61. PMC: 3328963. DOI: 10.1161/CIRCIMAGING.111.969923. View

Sergeyeva O, Gorodetskaya I, Ramos R, Schiller B, Larive B, Raimann J . Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. J Nephrol. 2012; 25(3):302-9. DOI: 10.5301/jn.5000160. View

Woods J, Port F, Stannard D, Blagg C, Held P . Comparison of mortality with home hemodialysis and center hemodialysis: a national study. Kidney Int. 1996; 49(5):1464-70. DOI: 10.1038/ki.1996.206. View

10.

Cases A, Dempster M, Davies M, Gamble G . The experience of individuals with renal failure participating in home haemodialysis: an interpretative phenomenological analysis. J Health Psychol. 2011; 16(6):884-94. DOI: 10.1177/1359105310393541. View

11.

Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J . A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int. 2007; 11(4):468-77. DOI: 10.1111/j.1542-4758.2007.00229.x. View

12.

Hall Y, Larive B, Painter P, Kaysen G, Lindsay R, Nissenson A . Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol. 2012; 7(5):782-94. PMC: 3338281. DOI: 10.2215/CJN.10601011. View

13.

de Jager D, Grootendorst D, Jager K, van Dijk P, Tomas L, Ansell D . Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009; 302(16):1782-9. DOI: 10.1001/jama.2009.1488. View

14.

Jhamb M, Argyropoulos C, Steel J, Plantinga L, Wu A, Fink N . Correlates and outcomes of fatigue among incident dialysis patients. Clin J Am Soc Nephrol. 2009; 4(11):1779-86. PMC: 2774952. DOI: 10.2215/CJN.00190109. View

15.

Daugirdas J, Chertow G, Larive B, Pierratos A, Greene T, Ayus J . Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol. 2012; 23(4):727-38. PMC: 3312501. DOI: 10.1681/ASN.2011070688. View

16.

Kurella Tamura M, Larive B, Unruh M, Stokes J, Nissenson A, Mehta R . Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol. 2010; 5(8):1429-38. PMC: 2924414. DOI: 10.2215/CJN.01090210. View

17.

Roberts M, Polkinghorne K, McDonald S, Ierino F . Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis. 2011; 58(1):64-72. DOI: 10.1053/j.ajkd.2011.01.024. View

18.

Klarenbach S, Tonelli M, Pauly R, Walsh M, Culleton B, So H . Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial. J Am Soc Nephrol. 2013; 25(3):587-94. PMC: 3935585. DOI: 10.1681/ASN.2013040360. View

19.

Rocco M, Larive B, Eggers P, Beck G, Chertow G, Levin N . Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis. 2010; 57(1):90-100. PMC: 3058226. DOI: 10.1053/j.ajkd.2010.08.024. View

20.

Kaysen G, Larive B, Painter P, Craig A, Lindsay R, Rocco M . Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial. Am J Kidney Dis. 2010; 57(1):101-12. PMC: 3073398. DOI: 10.1053/j.ajkd.2010.08.021. View